zytiga
janssen-cilag international n.v. - abiraterone acetat - prostatiske neoplasmer - endokrine terapi - zytiga er angivet med prednison eller prednisolon for:behandling af metastatisk kastration resistent prostatakræft hos voksne mænd, der er asymptomatiske eller mildt symptomatisk efter svigt af androgen deprivation terapi i hvem kemoterapi er endnu ikke klinisk indicatedthe behandling af metastatisk kastration resistent prostatakræft hos voksne mænd, hvis sygdommen har udviklet sig på eller efter en docetaxel-baseret kemoterapi.
abiraterone accord
accord healthcare s.l.u. - abiraterone acetat - prostatiske neoplasmer - endokrine terapi - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
abiraterone krka
krka, d.d., novo mesto - abiraterone acetat - prostatiske neoplasmer - endokrine terapi - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.
improvac
zoetis belgium sa - synthetic peptide analogue of gnrf conjugated to diptheria toxoid - immunologiske stoffer til suidae - male pigs (from 8 weeks of age); female pigs (from 14 weeks of age) - male pigs:induction of antibodies against gnrf to produce a temporary immunological suppression of testicular function. for use as an alternative to physical castration for the reduction of boar taint caused by the key boar taint compound androstenone, in entire male pigs following the onset of puberty. en anden vigtig bidragyder til vildsvin, skatole, kan også reduceres som en indirekte virkning. aggressive og seksuelle (montering) adfærd reduceres også. female pigs:induction of antibodies against gnrf to produce a temporary immunological suppression of ovarian function (suppression of oestrus) in order to reduce the incidence of unwanted pregnancies in gilts intended for slaughter, and to reduce the associated sexual behaviour (standing oestrus).
pamorelin 22,5 mg depotinjektionsvæske, pulver og solvens til suspension
institut produits synthése (ipsen) ab - triptorelin - depotinjektionsvæske, pulver og solvens til suspension - 22,5 mg
pamorelin 11,25 mg depotinjektionsvæske, pulver og solvens til suspension
institut produits synthése (ipsen) ab - triptorelin - depotinjektionsvæske, pulver og solvens til suspension - 11,25 mg
triptorelin "orifarm" 11,25 mg depotinjektionsvæske, pulver og solvens til suspension
orifarm a/s - triptorelin - depotinjektionsvæske, pulver og solvens til suspension - 11,25 mg
pamorelin 3,75 mg depotinjektionsvæske, pulver og solvens til suspension
institut produits synthése (ipsen) ab - triptorelin - depotinjektionsvæske, pulver og solvens til suspension - 3,75 mg
leuprorelin "sandoz" 3,6 mg implantat, fyldt injektionssprøjte
sandoz a/s - leuprorelinacetat - implantat, fyldt injektionssprøjte - 3,6 mg
leuprorelin "sandoz" 5 mg implantat, fyldt injektionssprøjte
sandoz a/s - leuprorelinacetat - implantat, fyldt injektionssprøjte - 5 mg